Hyperventilation Effects on Bodily Self-Consciousness

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorUniversity of Fribourg

About this trial

This study examines how voluntary fast, deep breathing (hyperventilation) affects the way healthy adults perceive their own body. Participants wear a virtual-reality (VR) headset and see a virtual body; a glowing halo around it either pulses exactly in time with their own breathing or is time-shifted. During the study, breathing, heart activity, blood-oxygen level, the carbon-dioxide content of exhaled air, and brain activity (EEG, measured non-invasively from the scalp) are recorded continuously, and participants complete questionnaires about their experience.

The aim is to understand whether and how altered breathing changes the interplay between what people see and what they feel inside their body, and thereby the sense of being located within one's own body. The study uses a 2×2 within-subjects design crossing Breathing (normal vs. hyperventilation) with Visual synchrony (synchronous vs. asynchronous), with the asynchronous and normal-breathing conditions serving as within-subject controls.

No medication is administered and no medical device is being tested; the instruments used serve only for monitoring and measurement. Participation involves a screening visit (including a short, \~5-minute guided-hyperventilation tolerance test) and an experimental visit.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Healthy adult aged 18-55 years

Able to provide written informed consent

Normal or corrected-to-normal vision

Sufficient German or English to follow instructions and complete questionnaires

Disqualifiers

Cardiovascular or cerebrovascular disease posing a risk during hyperventilation (e.g., myocardial infarction or stroke within 12 months, significant/unstable cardiac disease, heart failure, uncontrolled/severe hypertension, aneurysm, Moyamoya)

Respiratory disease (asthma, COPD, restrictive lung disease, pulmonary fibrosis, recent severe lung infection, dyspnoea at rest)

Haematological disease (sickle cell disease or trait, severe anaemia)

Neurological disease (epilepsy or seizures, severe/recurrent migraine, neurodegenerative disorder)

Trial design

Design model

Crossover

Treatments tested in this trial

  • Voluntary hyperventilation (guided paced breathing)

    Other intervention

    Participants breathe deeper and faster than normal, maintaining continuous cyclic breathing without pauses between inhalation and exhalation, paced by a pre-recorded standardised voice guide in German or English with background music. The hyperventilation block comprises four cycles, each with a 10-minute guided paced-hyperventilation induction, a 2-minute VR exposure and a 3-minute post-exposure stack (BSC-Q, Mental Imagery Task, distress NRS); cycle 1 additionally includes a 2-minute hyperventilation-state Mental Imagery Task pre-test between the induction and the VR exposure. A 5-minute sustained-hyperventilation resting-state EEG window is collected between cycles 2 and 3, with the voice guide replaced by a soft drum pacing tone. Cumulative hyperventilation is approximately 45 minutes, followed by a single supervised recovery. EtCO2, SpO2, heart rate and heart rate variability (ECG) are monitored continuously under the protocol's tiered stop criteria.

  • Normal spontaneous breathing (within-subject control)

    Other intervention

    Within-subject control condition for the Breathing factor. Participants breathe at their natural spontaneous rate while receiving audio guidance from the same pre-recorded standardised voice guide and background music used in the hyperventilation condition, so that the auditory environment is held constant across conditions and only the breathing instruction differs. Delivered as two 8-minute normal-breathing cycles (3 minutes spontaneous breathing in VR, a 2-minute VR exposure, and a 3-minute post-exposure stack of BSC-Q, Mental Imagery Task and distress NRS), one with synchronous and one with asynchronous respiratory-visual feedback, seated in the experimental chair wearing the head-mounted display.

  • Synchronous respiratory-visual VR feedback

    Other intervention

    Respiratory-visual VR paradigm delivering contingent feedback; this is the measurement method through which bodily self-consciousness is assessed. Seated participants wear a head-mounted display showing a first-person view of a three-dimensional virtual body positioned about 2 metres in front of the viewpoint and seen from behind. A respiratory belt at the level of the umbilicus drives, in real time, a luminous halo surrounding the virtual body: the halo becomes increasingly visible during inspiration, reaches maximum luminosity at peak inspiration and fades during expiration, in synchrony with the participant's actual breathing. Each exposure lasts 2 minutes (120 seconds). Each participant receives one synchronous exposure in the normal-breathing block and two in the hyperventilation block.

  • Asynchronous respiratory-visual VR feedback

    Other intervention

    Respiratory-visual VR paradigm delivering non-contingent feedback; the control level of the Synchrony factor. Setup is identical to the synchronous condition (seated, head-mounted display, virtual body about 2 metres in front seen from behind, respiratory belt at the umbilicus), except that the halo modulation is phase-shifted and frequency-adjusted to 80% or 120% of the measured breathing frequency, so that the visual feedback never corresponds to the participant's respiratory state. Each exposure lasts 2 minutes (120 seconds). Each participant receives one asynchronous exposure in the normal-breathing block and two in the hyperventilation block.

Treatment groups

35 Participants
are divided into 2 treatment groups
Group A: Sequence A: synchronous-first (normal-breathing block)Experimental treatment 4 interventions
Group B: Sequence B: asynchronous-first (normal-breathing block)Experimental treatment 4 interventions

Trial outcomes

Primary outcomes

1

Mean Rating of Perceived Breathing Location in the Virtual Body: Bodily Self-Consciousness Questionnaire Item 1 (BSC-Q1)

Self-reported agreement with the statement "It seemed as if I was feeling my respiration in the virtual body", item 1 of the Bodily Self-Consciousness Questionnaire (BSC-Q). Rated on a 7-point Likert scale from -3 (totally disagree) to +3 (totally agree); minimum -3, maximum +3. Higher scores indicate that the participant's own breathing is felt more strongly to be located in the virtual body (a stronger illusion). This is a mechanistic outcome; neither a higher nor a lower score is a better or worse clinical outcome. Rated after each of the 6 virtual reality (VR) exposures (2 normal-breathing exposures, 4 hyperventilation cycles); the two hyperventilation cycles at each synchrony level are averaged within participant. Reported as the mean rating in each of the 4 conditions (Synchronous/Asynchronous x Normal breathing/Hyperventilation). Primary analysis: the Synchrony x Breathing interaction in a within-subjects linear mixed-effects model.

Time frame
Experimental visit (single visit, approximately 188 minutes); rated after each of the 6 VR exposures

Secondary outcomes

1

Mean Drift in Perceived Self-Location Toward the Virtual Body, Measured With the Mental Imagery Task (MIT)

Behavioural measure of perceived self-location, reported in centimetres. Participants stand still in virtual reality and watch a ball approach along the anterior-posterior body axis; the ball then disappears and they press a button when they imagine it reaching their own position. The position of the hidden ball along that axis at the moment of the button press is recorded as the estimate of perceived self-location (method of Nakul et al., Sci Rep 2020;10:6802, which records self-location as an anterior-posterior coordinate and reports drifts in centimetres). One value is reported per participant per condition: the drift, calculated as the coordinate recorded after the VR exposure minus the participant's own matched breathing-state pre-test coordinate. Positive values indicate relocation toward the virtual body; larger positive values indicate a stronger illusion. Secondary endpoint, analysed as the Synchrony x Breathing interaction in a mixed-effects model.

Time frame
Experimental visit (single visit, approximately 188 minutes); measured after each of the 6 VR exposures, each baseline-corrected against a matched breathing-state pre-test
2

Mean Rating of Perceived Breathing Synchrony With the Virtual Body: Bodily Self-Consciousness Questionnaire Item 2 (BSC-Q2)

Self-reported agreement with the statement "I felt as if the virtual body was breathing with me", item 2 of the Bodily Self-Consciousness Questionnaire (BSC-Q). Rated on a 7-point Likert scale from -3 (totally disagree) to +3 (totally agree); minimum -3, maximum +3. Higher scores indicate a stronger sense that the virtual body was breathing together with the participant. This is a mechanistic outcome; neither a higher nor a lower score is a better or worse clinical outcome. Rated after each of the 6 virtual reality (VR) exposures (2 normal-breathing exposures, 4 hyperventilation cycles); the two hyperventilation cycles at each synchrony level are averaged within participant. Reported as the mean rating in each of the 4 conditions (Synchronous/Asynchronous x Normal breathing/Hyperventilation). Secondary endpoint, analysed with a mixed-effects model analogous to the primary endpoint and reported with uncorrected p-values.

Time frame
Experimental visit (single visit, approximately 188 minutes); rated after each of the 6 VR exposures
3

Mean Rating of Self-Identification With the Virtual Body: Bodily Self-Consciousness Questionnaire Item 3 (BSC-Q3)

Self-reported agreement with the statement "I felt as if the virtual body was my body", item 3 of the Bodily Self-Consciousness Questionnaire (BSC-Q). Rated on a 7-point Likert scale from -3 (totally disagree) to +3 (totally agree); minimum -3, maximum +3. Higher scores indicate stronger self-identification with the virtual body. This is a mechanistic outcome; neither a higher nor a lower score is a better or worse clinical outcome. Rated after each of the 6 virtual reality (VR) exposures (2 normal-breathing exposures, 4 hyperventilation cycles); the two hyperventilation cycles at each synchrony level are averaged within participant. Reported as the mean rating in each of the 4 conditions (Synchronous/Asynchronous x Normal breathing/Hyperventilation). Secondary endpoint, analysed with a mixed-effects model analogous to the primary endpoint and reported with uncorrected p-values.

Time frame
Experimental visit (single visit, approximately 188 minutes); rated after each of the 6 VR exposures
4

Mean Rating of Being Located Outside the Physical Body: Bodily Self-Consciousness Questionnaire Item 4 (BSC-Q4)

Self-reported agreement with the statement "I felt as if I was outside my physical body", item 4 of the Bodily Self-Consciousness Questionnaire (BSC-Q). Rated on a 7-point Likert scale from -3 (totally disagree) to +3 (totally agree); minimum -3, maximum +3. Higher scores indicate a stronger sensation of being located outside the physical body. This is a mechanistic outcome; neither a higher nor a lower score is a better or worse clinical outcome. Rated after each of the 6 virtual reality (VR) exposures (2 normal-breathing exposures, 4 hyperventilation cycles); the two hyperventilation cycles at each synchrony level are averaged within participant. Reported as the mean rating in each of the 4 conditions (Synchronous/Asynchronous x Normal breathing/Hyperventilation). Secondary endpoint, analysed with a mixed-effects model analogous to the primary endpoint and reported with uncorrected p-values.

Time frame
Experimental visit (single visit, approximately 188 minutes); rated after each of the 6 VR exposures

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: